Finance

Lists
301207:SHE
Hualan Biological Vaccine Inc
19,12 CN¥
+0,84%
(+0,16) 1D
15 қаз., 15:04:10 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301207...
Open
18,71 CN¥
High
19,95 CN¥
Low
18,63 CN¥
Mkt. cap
11,60 млрд
Avg. vol.
8,62 млн
Volume
9,47 млн
P/E ratio
56,63
52-wk high
27,88 CN¥
52-wk low
15,43 CN¥
EPS
0,34 CN¥
Shares outstanding
601,03 млн
No. of employees
708
Open
18,71 CN¥
High
19,95 CN¥
Low
18,63 CN¥
Mkt. cap
11,60 млрд
Avg. vol.
8,62 млн
Volume
9,47 млн
P/E ratio
56,63
52-wk high
27,88 CN¥
52-wk low
15,43 CN¥
EPS
0,34 CN¥
Shares outstanding
601,03 млн
No. of employees
708
News stories
From web sources and news partners
About Hualan Biological Vaccine Inc
CEO-
Employees708
Founded2005 ж. 09 қар.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
746,03 млн
396,52 млн
26,78 млн
17,61 млн
Cost of goods sold
182,87 млн
139,72 млн
7,79 млн
2,63 млн
Cost of revenue
182,87 млн
139,72 млн
7,79 млн
2,63 млн
Research and development expenses
29,46 млн
39,52 млн
20,78 млн
23,01 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
390,72 млн
140,54 млн
18,65 млн
26,00 млн
Operating expense
471,76 млн
215,90 млн
-595,40 м.
40,39 млн
Total operating expenses
654,63 млн
355,62 млн
7,19 млн
43,02 млн
Operating income
91,39 млн
40,90 млн
19,58 млн
-25,41 млн
Other non operating income
-67,28 мың
59,40 мың
-24,32 мың
-14,95 мың
EBT including unusual items
126,43 млн
50,16 млн
40,47 млн
-5,02 млн
EBT excluding unusual items
108,71 млн
63,02 млн
34,60 млн
-9,36 млн
Income tax expense
14,91 млн
-453,17 м.
3,10 млн
-4,10 млн
Effective tax rate
11,80%
-0,90%
7,67%
81,62%
Other operating expenses
4,23 млн
3,16 млн
1,58 млн
1,38 млн
Net income
111,51 млн
50,61 млн
37,37 млн
-922,55 м.
Net profit margin
14,95%
12,76%
139,55%
-5,24%
Earnings per share
-
-
-
-
Interest and investment income
17,35 млн
22,10 млн
15,04 млн
16,07 млн
Interest expense
-
-
-
-
Net interest expenses
17,35 млн
22,10 млн
15,04 млн
16,07 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
126,49 млн
76,17 млн
54,85 млн
9,97 млн
Gain or loss from assets sale
-
204,77 м.
-
-
AI content may include mistakes. Learn more
Google қолданбалары